The growing demand for specific immunological study and therapeutic development has spurred significant progress in recombinant cytokine manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently manufactured using multiple expression systems, including bacterial hosts, higher cell cultures, and insect rep